BridgeMD
New treatment option for Primary Ciliary Dyskinesia
Official title Glycine and Magnesium+Thiamine for the Treatment of Primary Ciliary Dyskinesia
ClinicalTrials.gov ID: NCT06959251
What this study is testing
- What it's testing
- Patients with primary ciliary dyskinesia (PCD) have trouble with clearing their bronchi from mucus, which in the long-term may produce severe damage to the lungs. Currently, there is no specific treatment for PCD beyond supportive measures such as airway hydration and postural drainage.
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 5 and older
You may be able to join if
- Any sex.
- Age of 5 years or more.
- Diagnosis of primary ciliary dyskinesia (PCD) established according to international recommendations (Shapiro et al. Am J Respir Crit Care Med...
- Without respiratory exacerbations of PCD in the previous 30 days.
- Without acute respiratory infection in the previous 30 days.
You likely can't join if
- 1\. Participation in other research protocol involving therapeutic measures.
- Elimination Criteria:
- 1\. None.
See the full eligibility criteria
- Any sex.
- Age of 5 years or more.
- Diagnosis of primary ciliary dyskinesia (PCD) established according to international recommendations (Shapiro et al. Am J Respir Crit Care Med 2018;197(12):e24-e39, and Shapiro et al. Ped Pulmonol 2016;51:115-132).
- Without respiratory exacerbations of PCD in the previous 30 days.
- Without acute respiratory infection in the previous 30 days.
- Informed consent letter signed by the patient (if the patient's age is 18 years or more).
- Informed consent letter signed by the legal guardian, and assent letter signed by the patient (if the patient's age is \<18 years).
- 1\. Participation in other research protocol involving therapeutic measures.
- Elimination Criteria:
- 1\. None.
The study team makes the final eligibility decision.
Where it's taking place
- Mexico City, Mexico
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 5 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Mexico City, Mexico. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.